ПО-ВАЖНИ ПУБЛИКУВАНИ РАЗРАБОТКИ
1. Хранов, Л. Г., 1999. Когнитивни разстройства при шизофрения. Novartis Pharma
Services Inc., CSO, София; 80 стр., библ. 293 (МОНОГРАФИЯ).
2. Захариев, З., Хранов, Л., 1999. Епилепсия. Sanofi-Synthelabo, София; 213
стр., библ. 637. ISBN 954-90504-1-6 (МОНОГРАФИЯ).
3. Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y.,
Keet, I. P. M., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger,
J., Hummer, M., Dollfus, S., Lopez Ibor, J.-J., Hranov, L. G., Gaebel, W.,
Peuskens, J., Lindefors, N., Riecher-R?ssler, A., Grobbee, D. E., for the
EUFEST study group, 2008. Effectiveness of antipsychotic drugs in first-episode
schizophrenia and schizophreniform disorder: an open randomized clinical trial.
The Lancet 371, 1085-1097. IF 28.400.
4. Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe
RS, Boter H, Keet IPM, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M,
Dollfus S, L?pez-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riechler-R?ssler
A, Kahn RS, 2009. Cognitive effects of antipsychotic drugs in first-episode
schizophrenia and schizophreniform disorder: a randomized, open-label clinical
trial (EUFEST). Am J Psychiatry 166, 675-682. IF 10.545
5. Galderisi, S., Davidson, M., Kahn, R., Mucci, A., Boter H., Gheorghe M.
D., Rybakowski, J. K., Libiger, J., Dollfus, S., L?pez-Ibor, J. J., Peuskens,
J., Hranov, L. G.,, Fleischhacker, W. W and the EUFEST group, 2009. Correlates
of cognitive impairment in first episode schizophrenia: the EUFEST Study.
Schizophr Res 115, 104-14. IF 4.174
6. Bowden, C., Mosolov, S., Hranov, L., Chen, E., Habil, H., Kongsakon R.,
Manfredi, R. D, Lin, H-N., 2010. A twelve-week, open, randomized trial comparing
sodium valproate with lithium in bipolar I patients suffering from a manic
or mixed episode: the VALID study. Int Clin Psychopharmacol 25, 60-67. IF
2.928.